Literature DB >> 9449203

Autocrine and paracrine actions of breast tumor aromatase. A three-dimensional cell culture study involving aromatase transfected MCF-7 and T-47D cells.

X Z Sun1, D Zhou, S Chen.   

Abstract

Stable aromatase-expressing MCF-7 and T-47D cell lines (i.e. MCF-7aro and T-47Daro) have been prepared by aromatase cDNA transfection and G418 (neomycin) selection. MCF-7aro was further subjected to a clonal purification. Aromatase activity in the transfected MCF-7 and T-47D cell lines was determined to be 73 +/- 6 pmol/mg/h and 48 +/- 4 pmol/mg/h, respectively. It is thought that these cell lines express aromatase in a stable manner, as demonstrated by a steady expression of the enzyme during culture in the absence of G418. The growth of these cells could be stimulated by androgens (1-10 nM) as demonstrated through a spheroid culture method. The androgen-stimulated growth could be suppressed by 4-hydroxyandrostenedione (4-OHA) (0.01-0.1 mM) or tamoxifen (50 nM-1 microM). In order to test the hypothesis that tumor aromatase can affect breast tumor growth in a paracrine manner, we have carried out cell culture experiments by co-culturing MCF-7 cells with either MCF-7aro or T-47Daro cells. Testosterone (1 nM) increased cell growth to a similar degree for MCF-7/MCF-7aro co-culture (0.75 x 10(6) cells each type) as with MCF-7aro only (2- to 3-fold). In addition, the enzyme activities remained unchanged for MCF-7/MCF-7aro co-culture samples with and without androgen treatment, indicating that estrogen produced by transfected cells can also stimulate the growth of untransfected cells. The androgen response could be inhibited by an addition of 4-OHA (0.01-0.1 mM). For MCF-7/T-47Daro co-culture experiments, a clear induction of cell growth by androgen was observed, and the level of the increase was similar to that on T-47Daro only. However, for either culture with T-47D only or with MCF-7/T-47Daro co-culture, the aromatase activity was found to increase significantly after testosterone treatment. T-47Daro cells were not subjected to a clonal purification, and it is therefore thought that the androgen treatment may selectively stimulate the growth of high aromatase-expressing T-47Daro cells. These results indicate that estrogen synthesized by tumor aromatase can stimulate breast tumor growth in both an autocrine and a paracrine manner.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9449203     DOI: 10.1016/s0960-0760(97)00068-x

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  22 in total

1.  The HDAC inhibitor LBH589 (panobinostat) is an inhibitory modulator of aromatase gene expression.

Authors:  Shiuan Chen; Jingjing Ye; Ikuko Kijima; Dean Evans
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-01       Impact factor: 11.205

Review 2.  Structural and functional characterization of aromatase, estrogen receptor, and their genes in endocrine-responsive and -resistant breast cancer cells.

Authors:  Hei Jason Chan; Karineh Petrossian; Shiuan Chen
Journal:  J Steroid Biochem Mol Biol       Date:  2015-08-13       Impact factor: 4.292

3.  Proteomic signatures of acquired letrozole resistance in breast cancer: suppressed estrogen signaling and increased cell motility and invasiveness.

Authors:  Syreeta L Tilghman; Ian Townley; Qiu Zhong; Patrick P Carriere; Jin Zou; Shawn D Llopis; Lynez C Preyan; Christopher C Williams; Elena Skripnikova; Melyssa R Bratton; Qiang Zhang; Guangdi Wang
Journal:  Mol Cell Proteomics       Date:  2013-05-23       Impact factor: 5.911

4.  Pomegranate ellagitannin-derived compounds exhibit antiproliferative and antiaromatase activity in breast cancer cells in vitro.

Authors:  Lynn S Adams; Yanjun Zhang; Navindra P Seeram; David Heber; Shiuan Chen
Journal:  Cancer Prev Res (Phila)       Date:  2010-01

5.  MCF-7aro/ERE, a novel cell line for rapid screening of aromatase inhibitors, ERalpha ligands and ERRalpha ligands.

Authors:  Ki Lui; Takaya Tamura; Taisuke Mori; Dujin Zhou; Shiuan Chen
Journal:  Biochem Pharmacol       Date:  2008-05-01       Impact factor: 5.858

Review 6.  What do we know about the mechanisms of aromatase inhibitor resistance?

Authors:  Shiuan Chen; Selma Masri; Xin Wang; Sheryl Phung; Yate-Ching Yuan; Xiwei Wu
Journal:  J Steroid Biochem Mol Biol       Date:  2006-10-19       Impact factor: 4.292

7.  Inhibition of the proliferation of acquired aromatase inhibitor-resistant breast cancer cells by histone deacetylase inhibitor LBH589 (panobinostat).

Authors:  Makoto Kubo; Noriko Kanaya; Karineh Petrossian; Jingjing Ye; Charles Warden; Zheng Liu; Reiki Nishimura; Tomofumi Osako; Masayuki Okido; Kazuo Shimada; Masato Takahashi; Peiguo Chu; Yate-Ching Yuan; Shiuan Chen
Journal:  Breast Cancer Res Treat       Date:  2012-11-18       Impact factor: 4.872

8.  The role of microRNA-128a in regulating TGFbeta signaling in letrozole-resistant breast cancer cells.

Authors:  Selma Masri; Zheng Liu; Sheryl Phung; Emily Wang; Yate-Ching Yuan; Shiuan Chen
Journal:  Breast Cancer Res Treat       Date:  2010-01-07       Impact factor: 4.872

9.  Characterization of the weak estrogen receptor alpha agonistic activity of exemestane.

Authors:  Selma Masri; Ki Lui; Sheryl Phung; Jingjing Ye; Dujin Zhou; Xin Wang; Shiuan Chen
Journal:  Breast Cancer Res Treat       Date:  2008-08-03       Impact factor: 4.872

10.  Molecular characterization of aromatase inhibitor-resistant, tamoxifen-resistant and LTEDaro cell lines.

Authors:  Selma Masri; Sheryl Phung; Xin Wang; Shiuan Chen
Journal:  J Steroid Biochem Mol Biol       Date:  2009-11-06       Impact factor: 4.292

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.